Loading the company…
Loading the company…
Families: Radiofrequency ablation (facet, genicular, basivertebral).
All companies · Product and company coverage
In the last ten years FDA made 2 decisions for Neuroone Medical Technologies (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 1 procedure family, the most in 2025 (1). The latest was on 2025-08-15.
| Family | Decisions on record |
|---|---|
| Radiofrequency ablation (facet, genicular, basivertebral) | 2 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2025-08-15 | 510(k) | K251243 | OneRF Trigeminal Nerve Radiofrequency Probes |
| 2023-12-06 | 510(k) | K231675 | OneRF Ablation System |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Neuroone Medical Technologies.
In 2025, Neuroone Medical Technologies reported engagement with 6 surgeons and other clinicians in the states MedaRep covers, worth $244 in consulting, speaking, meals and travel for its device products, the most in Florida ($163 to 4). Royalties are left out.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: Florida ($163, 4 engaged), Georgia ($41, 1 engaged), Ohio ($41, 1 engaged).